Acetic acid, sodium salt (2:1)
Common Name: |
Acetic acid, sodium salt (2:1) |
IUPAC Name: |
sodium;acetic acid;acetate |
Molecular Formula: |
C10H9NaO4 |
SMILES: |
CC(=O)O.CC(=O)[O-].[Na+] |
Inchi: |
1S/2C2H4O2.Na/c2*1-2(3)4;/h2*1H3,(H,3,4);/q;;+1/p-1 |
Inchi Key: |
BHZOKUMUHVTPBX-UHFFFAOYSA-M |
Cas No: |
126-96-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
216.17 |
Mass (g/mol) |
142.024 |
Molar Refractivity |
49.68 |
Net Charge |
|
HBD |
1 |
HBA |
4 |
Rt Bonds |
3 |
Rings |
|
TPSA |
69.59 |
Hetero Atoms |
|
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
323.00 to 329.00 |
Boiling Point (°C@760.00mm Hg) |
117.10 |
Vapor Pressure (mmHg@25.00 °C) |
13.9 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.10 |
LogP |
|
iLOGP |
-10.92 |
XLOGP3 |
1.51 |
WLOGP |
0.05 |
MLOGP |
1.00 |
ESOL Log S |
-2.23 |
ESOL Solubility (mg/ml) |
1.27 |
ESOL Solubility (mol/l) |
0.006 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.58 |
Ali Solubility (mg/ml) |
0.57 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.42 |
Silicos-IT Solubility (mg/ml) |
8.28 |
Silicos-IT Solubility (mol/l) |
0.04 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
1 |
Log Kp (cm/s) |
-6.55 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
-0.167 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.275 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |